Symptom management through electronic patient-reported outcome (ePRO)-based intervention in patients with breast cancer treated with abemaciclib: Primary results from the LIBRA study, a phase II randomized controlled trial

被引：0
|
作者：
Takano, Toshimi
Hayashida, Tetsu
Nagayama, Aiko
Ozaki, Yukinori
Takahashi, Maiko
Seki, Tomoko
Yokoe, Takamichi
Aoyama, Yosuke
Kizawa, Rika
Nishimura, Meiko
Hosonaga, Mari
Hara, Fumikata
Kobayashi, Takayuki
Ueno, Takayuki
Kitagawa, Yuko
机构：
[1] Japanese Fdn Canc Res JFCR, Canc Inst Hosp, Koto Ku, Tokyo, Japan
[2] Keio Univ, Sch Med, Tokyo, Japan
[3] Keio Univ, Sch Med, Gen Surg, Shinjuku Ku, Tokyo, Japan
[4] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Breast Med Oncol, Tokyo, Japan
[5] JFCR, Canc Inst Hosp, Dept Breast Oncol, Tokyo, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
11110
引用
收藏
页数：1
相关论文
共 50 条
  • [41] PRO-P: evaluating the effect of electronic patient-reported outcome measures monitoring compared with standard care in prostate cancer patients undergoing surgery-study protocol for a randomized controlled trial
    Al-Monajjed, Rouvier
    Albers, Peter
    Droop, Johanna
    Fugmann, Dominik
    Noldus, Joachim
    Palisaar, Rein-Jueri
    Ritter, Manuel
    Ellinger, Joerg
    Krausewitz, Philipp
    Truss, Michael
    Hadaschik, Boris
    Gruenwald, Viktor
    Schrader, Andres-Jan
    Papavassilis, Philipp
    Ernstmann, Nicole
    Schellenberger, Barbara
    Moritz, Anna
    Kowalski, Christoph
    Hellmich, Martin
    Heiden, Pierce
    Hagemeier, Anna
    Horenkamp-Sonntag, Dirk
    Giessing, Markus
    Pauler, Luis
    Dieng, Sebastian
    Peters, Maria
    Feick, Guenter
    Karger, Andre
    TRIALS, 2024, 25 (01)
  • [42] Patient-Reported Outcome Results from the Open-Label Randomized Phase III SELECT BC Trial Evaluating First-Line S-1 Therapy for Metastatic Breast Cancer
    Kawahara, Takuya
    Shimozuma, Kojiro
    Shiroiwa, Takeru
    Hagiwara, Yasuhiro
    Uemura, Yukari
    Watanabe, Takanori
    Taira, Naruto
    Fukuda, Takashi
    Ohashi, Yasuo
    Mukai, Hirofumi
    ONCOLOGY, 2018, 94 (02) : 107 - 115
  • [43] Expressive writing intervention and self-reported physical health out-comes - Results from a nationwide randomized controlled trial with breast cancer patients
    Jensen-Johansen, Mikael B.
    O'Toole, Mia S.
    Christensen, Soren
    Valdimarsdottir, Heiddis
    Zakowski, Sandra
    Bovbjerg, Dana H.
    Jensere, Anders B.
    Zachariae, Robert
    PLOS ONE, 2018, 13 (02):
  • [44] Patient-Reported Outcomes for Patients with Previously Treated Small Cell Lung Cancer Receiving Tarlatamab: Results from the DeLLphi-301 Phase 2 Trial
    Hummel, Horst-Dieter
    Ahn, Myung-Ju
    Blackhall, Fiona
    Reck, Martin
    Akamatsu, Hiroaki
    Ramalingam, Suresh S.
    Borghaei, Hossein
    Johnson, Melissa
    Dirnberger, Franziska
    Cocks, Kim
    Huang, Shuang
    Mukherjee, Sujoy
    Paz-Ares, Luis
    ADVANCES IN THERAPY, 2025, : 1950 - 1964
  • [45] Epoetin Alfa Improves Anemia and Anemia-Related, Patient-Reported Outcomes in Patients with Breast Cancer Receiving Myelotoxic Chemotherapy: Results of a European, Multicenter, Randomized, Controlled Trial
    Pronzato, Paolo
    Cortesi, Enrico
    Van der Rut, Carin C.
    Bols, Alain
    Moreno-Nogueira, Jose A.
    de Oliveira, Carlos Freire
    Barrett-Lee, Peter
    Ostler, Peter J.
    Rosso, Ricardo
    ONCOLOGIST, 2010, 15 (09): : 935 - 943
  • [46] Primary Results From the Randomized Phase II RIGHT Choice Trial of Premenopausal Patients With Aggressive HR+/HER2- Advanced Breast Cancer Treated With Ribociclib
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2023, 21 (02) : 4 - 5
  • [47] Statistical analysis plan for the PRO B study: open-label, superiority randomised controlled trial of alarm-based patient-reported outcome monitoring in patients with metastatic breast cancer
    Gebert, Pimrapat
    Karsten, Maria Margarete
    Hage, Anna Maria
    Dordevic, Adam David
    Grittner, Ulrike
    TRIALS, 2024, 25 (01)
  • [48] PRO B: evaluating the effect of an alarm-based patient-reported outcome monitoring compared with usual care in metastatic breast cancer patients-study protocol for a randomised controlled trial
    Karsten, Maria Margarete
    Kuehn, Friedrich
    Pross, Therese
    Blohmer, Jens-Uwe
    Hage, Anna Maria
    Fischer, Felix
    Rose, Matthias
    Grittner, Ulrike
    Gebert, Pimrapat
    Ferencz, Julia
    Pauler, Luis
    Breidenbach, Clara
    Kowalski, Christoph
    TRIALS, 2021, 22 (01)
  • [49] Statistical analysis plan for the PRO B study: open-label, superiority randomised controlled trial of alarm-based patient-reported outcome monitoring in patients with metastatic breast cancer
    Pimrapat Gebert
    Maria Margarete Karsten
    Anna Maria Hage
    Adam David Dordevic
    Ulrike Grittner
    Trials, 25
  • [50] Patient-Reported Outcomes of Azelaic Acid Foam 15% for Patients With Papulopustular Rosacea: Secondary Efficacy Results From a Randomized, Controlled, Double-blind, Phase 3 Trial
    Tyring, Stephen
    Solomon, James A.
    Staedtler, Gerald
    Lott, Jason P.
    Nkulikiyinka, Richard
    Shakery, Kaweh
    CUTIS, 2016, 98 (04): : 269 - 275
12345